159 related articles for article (PubMed ID: 37795580)
1. Sink or swim: Does a worm paralysis phenotype hold clues to neurodegenerative disease?
Rodriguez P; Blakely RD
J Cell Physiol; 2024 Jun; 239(6):e31125. PubMed ID: 37795580
[TBL] [Abstract][Full Text] [Related]
2. Glial Expression of the Caenorhabditis elegans Gene swip-10 Supports Glutamate Dependent Control of Extrasynaptic Dopamine Signaling.
Hardaway JA; Sturgeon SM; Snarrenberg CL; Li Z; Xu XZ; Bermingham DP; Odiase P; Spencer WC; Miller DM; Carvelli L; Hardie SL; Blakely RD
J Neurosci; 2015 Jun; 35(25):9409-23. PubMed ID: 26109664
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1.
Robinson SB; Refai O; Hardaway JA; Sturgeon S; Popay T; Bermingham DP; Freeman P; Wright J; Blakely RD
PLoS One; 2019; 14(5):e0216417. PubMed ID: 31083672
[TBL] [Abstract][Full Text] [Related]
4. Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis.
Hardaway JA; Hardie SL; Whitaker SM; Baas SR; Zhang B; Bermingham DP; Lichtenstein AJ; Blakely RD
G3 (Bethesda); 2012 Aug; 2(8):961-75. PubMed ID: 22908044
[TBL] [Abstract][Full Text] [Related]
5. The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.
Bermingham DP; Hardaway JA; Refai O; Marks CR; Snider SL; Sturgeon SM; Spencer WC; Colbran RJ; Miller DM; Blakely RD
J Neurosci; 2017 Sep; 37(38):9288-9304. PubMed ID: 28842414
[TBL] [Abstract][Full Text] [Related]
6. Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.
Refai O; Blakely RD
Neurochem Int; 2019 Feb; 123():59-68. PubMed ID: 29800604
[TBL] [Abstract][Full Text] [Related]
7. Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.
Bermingham DP; Hardaway JA; Snarrenberg CL; Robinson SB; Folkes OM; Salimando GJ; Jinnah H; Blakely RD
Neurochem Int; 2016 Sep; 98():122-8. PubMed ID: 26850478
[TBL] [Abstract][Full Text] [Related]
8. Modeling neurodegenerative diseases in Caenorhabditis elegans.
Li J; Le W
Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative conditions associated with ageing: a molecular interplay?
Troulinaki K; Tavernarakis N
Mech Ageing Dev; 2005 Jan; 126(1):23-33. PubMed ID: 15610759
[TBL] [Abstract][Full Text] [Related]
10. Towards Understanding Neurodegenerative Diseases: Insights from
Wu Y; Chen Y; Yu X; Zhang M; Li Z
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
[TBL] [Abstract][Full Text] [Related]
11. 3-Hydroxyanthranilic Acid Delays Paralysis in
Hull BT; Miller KM; Corban C; Backer G; Sheehan S; Korstanje R; Sutphin GL
Biomolecules; 2024 May; 14(5):. PubMed ID: 38786006
[TBL] [Abstract][Full Text] [Related]
12. Glial loss of the metallo β-lactamase domain containing protein, SWIP-10, induces age- and glutamate-signaling dependent, dopamine neuron degeneration.
Gibson CL; Balbona JT; Niedzwiecki A; Rodriguez P; Nguyen KCQ; Hall DH; Blakely RD
PLoS Genet; 2018 Mar; 14(3):e1007269. PubMed ID: 29590100
[TBL] [Abstract][Full Text] [Related]
13. An open-source analytical platform for analysis of C. elegans swimming-induced paralysis.
Hardaway JA; Wang J; Fleming PA; Fleming KA; Whitaker SM; Nackenoff A; Snarrenberg CL; Hardie SL; Zhang B; Blakely RD
J Neurosci Methods; 2014 Jul; 232():58-62. PubMed ID: 24792527
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.
Wang YA; Kammenga JE; Harvey SC
Hum Genomics; 2017 May; 11(1):12. PubMed ID: 28545550
[TBL] [Abstract][Full Text] [Related]
15. Dopamine signaling in C. elegans is mediated in part by HLH-17-dependent regulation of extracellular dopamine levels.
Felton CM; Johnson CM
G3 (Bethesda); 2014 Apr; 4(6):1081-9. PubMed ID: 24709946
[TBL] [Abstract][Full Text] [Related]
16. The contribution of
Liang JJH; McKinnon IA; Rankin CH
J Neurogenet; 2020; 34(3-4):527-548. PubMed ID: 32772603
[TBL] [Abstract][Full Text] [Related]
17. Swimming Induced Paralysis to Assess Dopamine Signaling in Caenorhabditis elegans.
Kudumala S; Sossi S; Carvelli L
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31009010
[TBL] [Abstract][Full Text] [Related]
18. A new role for laminins as modulators of protein toxicity in Caenorhabditis elegans.
Jensen LT; Møller TH; Larsen SA; Jakobsen H; Olsen A
Aging Cell; 2012 Feb; 11(1):82-92. PubMed ID: 22051349
[TBL] [Abstract][Full Text] [Related]
19. Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout Mice.
Ceyhan B; Nategh P; Neghabi M; LaMar JA; Konjalwar S; Rodriguez P; Hahn MK; Gross M; Grumbar G; Salleng KJ; Blakely RD; Ranji M
IEEE J Transl Eng Health Med; 2024; 12():298-305. PubMed ID: 38410184
[TBL] [Abstract][Full Text] [Related]
20. Caenorhabditis elegans: a useful tool to decipher neurodegenerative pathways.
Johnson JR; Jenn RC; Barclay JW; Burgoyne RD; Morgan A
Biochem Soc Trans; 2010 Apr; 38(2):559-63. PubMed ID: 20298221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
